MedicineHumansAdenocarcinoma of LungAntineoplastic AgentsCarcinomaNon-Small-Cell Lung
Furmonertinib in lung adenocarcinoma with EGFR exon 20 insertion mutation: A case report of positive outcome.
Qilin Wang, Beilei Zeng, Chuanyu You, Tian Xu, Xinyu Chen, Xueping Yang, Juncai Ye, Yan Gui
Published: 202610.1097/MD.0000000000046998
Abstract
RATIONALE: epidermal growth factor receptor (EGFR) mutations play a pivotal role in non-small cell lung cancer (NSCLC), with the EGFR exon 20 insertion (EGFR20ins) mutation being the third most prevalent alteration in the EGFR gene. Patients harborin…
Preview only. Read the full abstract at the source